CRM Comparison

Veeva Vault CRM vs HubSpot CRM (2026)

The real question behind this matchup is whether your company genuinely needs a life-sciences CRM. Veeva costs a median $211,872 a year and is built for regulated HCP engagement; HubSpot starts free and is built for everyone else.

TL;DR

  • Veeva Vault CRM is a life-sciences-only platform for pharma, biotech, and medtech commercial teams — HCP management, territory planning, events compliance, and MLR-governed engagement. No public price list; roughly $120–$150 per named user per month, median annual contract $211,872.
  • HubSpot CRM is a horizontal all-in-one: free tier, Starter at $20/seat, Professional at $90/seat annually plus a mandatory $1,500 onboarding fee, Enterprise at $150/seat plus $3,500.
  • The price gap is enormous and almost beside the point. Choosing wrong in either direction is expensive — one way you overpay by six figures, the other way you fail an inspection.
  • Start with a compliance question, not a budget question.

The test that decides this

Ask three things about your commercial operation. Does your promotional content require medical, legal, and regulatory review before a rep can show it? Do your field interactions with healthcare providers need auditable capture that would survive an inspection? Is your customer master data reconciled against an industry reference source rather than whatever your reps typed in?

Three yeses and HubSpot is not a candidate, regardless of price. Vault CRM's premium buys HCP management, territory and key account planning, events compliance, and native connections into Veeva's own data estate — OpenData, Link, Compass, Network MDM. Those are not features a horizontal CRM adds later; they're the reason the category exists.

Three noes and you are looking at a $211,872 median contract to solve problems you don't have.

The awkward answers live in the middle. Early-stage biotechs pre-commercialization, medtech companies selling to hospital procurement rather than prescribers, and life-sciences service providers all sit in territory where a horizontal CRM often does the job for years.

What Veeva actually costs

Veeva publishes nothing, so the numbers come from contract data and independent analysis. Standard editions land between roughly $1,000 and $2,000+ per user per year, with large organizations typically at $1,500–$1,800. Multi-channel reps — those with remote detailing and approved email alongside face-to-face calls — sit at the top of that band.

Licensing is per named user, not concurrent, which makes deprovisioning a live cost issue. Every rep on leave, every contractor, every seasonal field hire consumes a license until someone removes them. On a 400-license deployment, a ten percent difference in how "named user" is defined is $60,000 a year, which makes that definition one of the more productive things to negotiate.

Implementation adds $10,000–$50,000 for small and mid-sized deployments and considerably more at global pharma scale, where a systems integrator and validation documentation enter the picture. A 150-rep field force at $1,650 per user is about $247,500 in licenses; year one lands near $300,000 before any other Vault module.

What HubSpot actually costs

HubSpot's arithmetic is more legible but has its own traps. The free tier genuinely works for two users with contacts, deals, forms, and basic ticketing. Starter is $20 per seat. Then there's a cliff: Professional at $90 per seat annually, with nothing in between, and the features that force the jump are specific — sequences, custom report builder, forecasting, playbooks.

The onboarding fees hit small teams hardest. At five seats, the $1,500 Professional fee adds 28% to year one; at fifty seats it's noise. And Marketing Hub bills on marketing contacts rather than seats, so crossing a threshold after a webinar or a trade-show list import raises the bill automatically with nobody at your company approving it.

A twenty-person team on Professional pays $23,100 in year one. That is roughly a tenth of a mid-sized Veeva deployment, and it does not attempt the same job.

The ecosystem argument runs both directions

Veeva's proposition is a connected estate — CRM sitting alongside Vault QMS, RIM, and Clinical on shared data. That median $211,872 contract usually reflects several modules, not CRM alone. If you already run Vault products, buying CRM is an expansion with real negotiating leverage. If you don't and never will, you're paying enterprise prices for a fraction of what makes the platform worth them.

HubSpot's ecosystem is the opposite shape: 1,500+ integrations across every industry, HubSpot Academy for training, and a marketing automation layer that is genuinely strong. What it doesn't have is anything resembling regulated-industry compliance tooling. Biotech appears in HubSpot's tag list because biotechs run marketing, not because HubSpot handles approved email or MLR workflow.

Who should pick what

  • Commercial-stage pharma or biotech with a field force calling on prescribers → Veeva Vault CRM. There are few credible alternatives, and cheaper ones don't connect to your regulatory and quality systems.
  • Pre-commercial biotech, or medtech selling to procurement rather than clinicians → HubSpot, and revisit when a field force and MLR workflow actually exist.
  • Life-sciences service companies, CROs, and suppliers selling B2B into the industry → HubSpot. You're in the sector, not regulated by it in the way Veeva addresses.
  • Small life-sciences commercial teams where $1,500 per user is disproportionate → look at narrower industry vendors before defaulting to Veeva; the compliance ground is covered at lower license cost.
  • Marketing-led companies in any other industry → HubSpot Professional, and only after checking whether Starter holds.

Bottom line

These products rarely belong in the same evaluation, and when they do it's usually because a life-sciences company is trying to work out whether it has crossed into regulated commercial operations yet. That crossing is a real event with a date attached — first field rep hired, first MLR-reviewed piece of promotional content, first inspection exposure. Before it, HubSpot is defensible and cheap. After it, Veeva's price stops being a comparison and starts being a cost of operating.

Veeva publishes no rates, so treat every figure here as third-party estimate and confirm directly. HubSpot's list prices move most years — check hubspot.com/pricing before budgeting.